[Mn(PaPy2Q)(NO)]ClO4, a Near-Infrared Light activated release of Nitric Oxide drug as a nitric oxide donor for therapy of human prostate cancer cells in vitro and in vivo

This study was the first to investigate the synthesis of near-infrared light-sensitive NO prodrug [Mn(PaPy2Q)(NO)]ClO4, and detection the amount of NO released by the drug in different time and near infrared light (10 mW, 20 mW). It showed that with the increase of light power, the time required for...

Full description

Bibliographic Details
Main Authors: Yuwan Zhao, Zhuo Li, Huancheng Tang, Shanhong Lin, Wenfeng Zeng, Dongcai Ye, Xin Zeng, Qiuming Luo, Jianwei Li, Zhixian Ao, Jierong Mo, Lixin Chen, Yiqiu Yang, Yunsheng Huang, Jianjun Liu
Format: Article
Language:English
Published: Elsevier 2021-05-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332221001736
id doaj-3741385dee6e479ebf79a4ab9a32e231
record_format Article
spelling doaj-3741385dee6e479ebf79a4ab9a32e2312021-07-15T04:26:53ZengElsevierBiomedicine & Pharmacotherapy0753-33222021-05-01137111388[Mn(PaPy2Q)(NO)]ClO4, a Near-Infrared Light activated release of Nitric Oxide drug as a nitric oxide donor for therapy of human prostate cancer cells in vitro and in vivoYuwan Zhao0Zhuo Li1Huancheng Tang2Shanhong Lin3Wenfeng Zeng4Dongcai Ye5Xin Zeng6Qiuming Luo7Jianwei Li8Zhixian Ao9Jierong Mo10Lixin Chen11Yiqiu Yang12Yunsheng Huang13Jianjun Liu14Laboratory of Urology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, ChinaLaboratory of Urology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, ChinaLaboratory of Urology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, ChinaLaboratory of Urology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, ChinaLaboratory of Urology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, ChinaLaboratory of Urology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, ChinaLaboratory of Urology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, ChinaLaboratory of Urology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, ChinaLaboratory of Urology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, ChinaLaboratory of Urology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, ChinaLaboratory of Urology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, ChinaLaboratory of Urology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, ChinaSchool of Pharmacy, Guangdong Medical University, Xincheng Ave, Songshan Lake Technology Park, Dongguan 523808, ChinaSchool of Pharmacy, Guangdong Medical University, Xincheng Ave, Songshan Lake Technology Park, Dongguan 523808, China; Corresponding authors.Laboratory of Urology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, China; Corresponding authors.This study was the first to investigate the synthesis of near-infrared light-sensitive NO prodrug [Mn(PaPy2Q)(NO)]ClO4, and detection the amount of NO released by the drug in different time and near infrared light (10 mW, 20 mW). It showed that with the increase of light power, the time required for the drug to release NO was shortened, and we selected 20 mW, 10 min as a follow-up study of light power and irradiation time while ensuring the near-infrared light did not affect tumor cells. The cells were irradiated with 20 mW of near-infrared light for 10 min at 6 h after treatment with the drug on PC-3, LNCaP and 22RV1 cells, and NO concentration and cell survival rate were tested at 12 h, 24 h and 48 h. Experiments showed that NO concentration remained stable within 48 h and [Mn(PaPy2Q)(NO)]ClO4 inhibited the proliferation of cells in a concentration and time-dependent manner. Then we also found that [Mn(PaPy2Q)(NO)]ClO4 increased the expression of apoptosis-related proteins (PARP, Bax, Caspase 3/9), inhibited the expression of BCl-2 and increased the activity level of Caspase 3/7, which showed [Mn(PaPy2Q)(NO)]ClO4 promoted prostate cancer cells apoptosis. Next, the results in xenograft mouse model showed that [Mn(PaPy2Q)(NO)]ClO4 also had anti-prostate cancer effects in vivo, and the NO concentration increased in the tumor after near-infrared light irradiation. After [Mn(PaPy2Q)(NO)]ClO4 treatment 6 weeks, tumor volume was significantly reduced, Ki67 and BrdU protein expression was significantly reduced. TUNEL assay results showed that [Mn(PaPy2Q)(NO)]ClO4 could promote the apoptosis of solid tumors in vivo and in a concentration-dependent manner.http://www.sciencedirect.com/science/article/pii/S0753332221001736Prostate cancerNO prodrugNear-infrared light sensitiveNude mouse xenograft
collection DOAJ
language English
format Article
sources DOAJ
author Yuwan Zhao
Zhuo Li
Huancheng Tang
Shanhong Lin
Wenfeng Zeng
Dongcai Ye
Xin Zeng
Qiuming Luo
Jianwei Li
Zhixian Ao
Jierong Mo
Lixin Chen
Yiqiu Yang
Yunsheng Huang
Jianjun Liu
spellingShingle Yuwan Zhao
Zhuo Li
Huancheng Tang
Shanhong Lin
Wenfeng Zeng
Dongcai Ye
Xin Zeng
Qiuming Luo
Jianwei Li
Zhixian Ao
Jierong Mo
Lixin Chen
Yiqiu Yang
Yunsheng Huang
Jianjun Liu
[Mn(PaPy2Q)(NO)]ClO4, a Near-Infrared Light activated release of Nitric Oxide drug as a nitric oxide donor for therapy of human prostate cancer cells in vitro and in vivo
Biomedicine & Pharmacotherapy
Prostate cancer
NO prodrug
Near-infrared light sensitive
Nude mouse xenograft
author_facet Yuwan Zhao
Zhuo Li
Huancheng Tang
Shanhong Lin
Wenfeng Zeng
Dongcai Ye
Xin Zeng
Qiuming Luo
Jianwei Li
Zhixian Ao
Jierong Mo
Lixin Chen
Yiqiu Yang
Yunsheng Huang
Jianjun Liu
author_sort Yuwan Zhao
title [Mn(PaPy2Q)(NO)]ClO4, a Near-Infrared Light activated release of Nitric Oxide drug as a nitric oxide donor for therapy of human prostate cancer cells in vitro and in vivo
title_short [Mn(PaPy2Q)(NO)]ClO4, a Near-Infrared Light activated release of Nitric Oxide drug as a nitric oxide donor for therapy of human prostate cancer cells in vitro and in vivo
title_full [Mn(PaPy2Q)(NO)]ClO4, a Near-Infrared Light activated release of Nitric Oxide drug as a nitric oxide donor for therapy of human prostate cancer cells in vitro and in vivo
title_fullStr [Mn(PaPy2Q)(NO)]ClO4, a Near-Infrared Light activated release of Nitric Oxide drug as a nitric oxide donor for therapy of human prostate cancer cells in vitro and in vivo
title_full_unstemmed [Mn(PaPy2Q)(NO)]ClO4, a Near-Infrared Light activated release of Nitric Oxide drug as a nitric oxide donor for therapy of human prostate cancer cells in vitro and in vivo
title_sort [mn(papy2q)(no)]clo4, a near-infrared light activated release of nitric oxide drug as a nitric oxide donor for therapy of human prostate cancer cells in vitro and in vivo
publisher Elsevier
series Biomedicine & Pharmacotherapy
issn 0753-3322
publishDate 2021-05-01
description This study was the first to investigate the synthesis of near-infrared light-sensitive NO prodrug [Mn(PaPy2Q)(NO)]ClO4, and detection the amount of NO released by the drug in different time and near infrared light (10 mW, 20 mW). It showed that with the increase of light power, the time required for the drug to release NO was shortened, and we selected 20 mW, 10 min as a follow-up study of light power and irradiation time while ensuring the near-infrared light did not affect tumor cells. The cells were irradiated with 20 mW of near-infrared light for 10 min at 6 h after treatment with the drug on PC-3, LNCaP and 22RV1 cells, and NO concentration and cell survival rate were tested at 12 h, 24 h and 48 h. Experiments showed that NO concentration remained stable within 48 h and [Mn(PaPy2Q)(NO)]ClO4 inhibited the proliferation of cells in a concentration and time-dependent manner. Then we also found that [Mn(PaPy2Q)(NO)]ClO4 increased the expression of apoptosis-related proteins (PARP, Bax, Caspase 3/9), inhibited the expression of BCl-2 and increased the activity level of Caspase 3/7, which showed [Mn(PaPy2Q)(NO)]ClO4 promoted prostate cancer cells apoptosis. Next, the results in xenograft mouse model showed that [Mn(PaPy2Q)(NO)]ClO4 also had anti-prostate cancer effects in vivo, and the NO concentration increased in the tumor after near-infrared light irradiation. After [Mn(PaPy2Q)(NO)]ClO4 treatment 6 weeks, tumor volume was significantly reduced, Ki67 and BrdU protein expression was significantly reduced. TUNEL assay results showed that [Mn(PaPy2Q)(NO)]ClO4 could promote the apoptosis of solid tumors in vivo and in a concentration-dependent manner.
topic Prostate cancer
NO prodrug
Near-infrared light sensitive
Nude mouse xenograft
url http://www.sciencedirect.com/science/article/pii/S0753332221001736
work_keys_str_mv AT yuwanzhao mnpapy2qnoclo4anearinfraredlightactivatedreleaseofnitricoxidedrugasanitricoxidedonorfortherapyofhumanprostatecancercellsinvitroandinvivo
AT zhuoli mnpapy2qnoclo4anearinfraredlightactivatedreleaseofnitricoxidedrugasanitricoxidedonorfortherapyofhumanprostatecancercellsinvitroandinvivo
AT huanchengtang mnpapy2qnoclo4anearinfraredlightactivatedreleaseofnitricoxidedrugasanitricoxidedonorfortherapyofhumanprostatecancercellsinvitroandinvivo
AT shanhonglin mnpapy2qnoclo4anearinfraredlightactivatedreleaseofnitricoxidedrugasanitricoxidedonorfortherapyofhumanprostatecancercellsinvitroandinvivo
AT wenfengzeng mnpapy2qnoclo4anearinfraredlightactivatedreleaseofnitricoxidedrugasanitricoxidedonorfortherapyofhumanprostatecancercellsinvitroandinvivo
AT dongcaiye mnpapy2qnoclo4anearinfraredlightactivatedreleaseofnitricoxidedrugasanitricoxidedonorfortherapyofhumanprostatecancercellsinvitroandinvivo
AT xinzeng mnpapy2qnoclo4anearinfraredlightactivatedreleaseofnitricoxidedrugasanitricoxidedonorfortherapyofhumanprostatecancercellsinvitroandinvivo
AT qiumingluo mnpapy2qnoclo4anearinfraredlightactivatedreleaseofnitricoxidedrugasanitricoxidedonorfortherapyofhumanprostatecancercellsinvitroandinvivo
AT jianweili mnpapy2qnoclo4anearinfraredlightactivatedreleaseofnitricoxidedrugasanitricoxidedonorfortherapyofhumanprostatecancercellsinvitroandinvivo
AT zhixianao mnpapy2qnoclo4anearinfraredlightactivatedreleaseofnitricoxidedrugasanitricoxidedonorfortherapyofhumanprostatecancercellsinvitroandinvivo
AT jierongmo mnpapy2qnoclo4anearinfraredlightactivatedreleaseofnitricoxidedrugasanitricoxidedonorfortherapyofhumanprostatecancercellsinvitroandinvivo
AT lixinchen mnpapy2qnoclo4anearinfraredlightactivatedreleaseofnitricoxidedrugasanitricoxidedonorfortherapyofhumanprostatecancercellsinvitroandinvivo
AT yiqiuyang mnpapy2qnoclo4anearinfraredlightactivatedreleaseofnitricoxidedrugasanitricoxidedonorfortherapyofhumanprostatecancercellsinvitroandinvivo
AT yunshenghuang mnpapy2qnoclo4anearinfraredlightactivatedreleaseofnitricoxidedrugasanitricoxidedonorfortherapyofhumanprostatecancercellsinvitroandinvivo
AT jianjunliu mnpapy2qnoclo4anearinfraredlightactivatedreleaseofnitricoxidedrugasanitricoxidedonorfortherapyofhumanprostatecancercellsinvitroandinvivo
_version_ 1721301978109181952